CVE-2026-123051 — LOW Vulnerability
CVE-2026-123051 is a LOW severity security vulnerability (CVSS 1.2/10) affecting affected software system. Technical vector analysis shows that an attacker can exploit this flaw via local access (AV:L) without authentication (PR:N) with zero user interaction (UI:N), posing a direct security risk to affected deployments.
📄 Official NVD / MITRE Original Record Text
The REV.exe module distributed with Farmasimplex contains embedded OAuth client credentials for integration with the IZS platform. An attacker with access to the executable could extract and reuse the credentials, potentially leading to unauthorized access to integration resources or manipulation of associated information, depending on the privileges granted and authentication controls in place.
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
CVE-2026-123051
CVSS 1.2/10 · LOW · 17.11.2026
Vector: CVSS:4.0/AV:L/AC:L/AT:N/PR:N/UI:N/VC:L/VI:L/VA:N/SC:N/SI:N/SA:N/E:U
━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━━
🎯 WHAT IS THIS VULNERABILITY?
Summary: The REV.exe module distributed with Farmasimplex contains embedded OAuth client credentials for integration with the IZS platform. An attacker with access to the executable could extract and reuse the credentials, potentially leading to unauthorized access to integration resources or manipulation of associated information, depending on the privileges granted and authentication controls in place.
⚡ ATTACK CHAIN
Local/physical access | no authentication required | no user interaction | low complexity.
🌍 REAL WORLD IMPACT
🛡️ REMEDIATION
→ Apply the vendor-released patch immediately.
→ Add WAF rule, create IDS alert for anomalous traffic.
⚠️ URGENCY
📌 Low priority — routine update sufficient.
────────────────────────────────────────
[Kural Tabanlı Otomatik Güvenlik Analizi]